BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/17/2014 3:13:00 PM | Browse: 1066 | Download: 983
Publication Name World Journal of Gastroenterology
Manuscript ID 9595
Country China
Received
2014-02-20 17:13
Peer-Review Started
2014-02-20 22:28
To Make the First Decision
2014-04-02 19:37
Return for Revision
2014-04-12 06:47
Revised
2014-05-04 20:46
Second Decision
2014-07-25 09:22
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-07-25 09:44
Articles in Press
2014-07-25 09:56
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-08-04 11:37
Typeset the Manuscript
2014-10-28 18:07
Publish the Manuscript Online
2014-11-17 15:12
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Recent studies of 5-fluorouracil resistance in pancreatic cancer
Manuscript Source Unsolicited Manuscript
All Author List Wei-Bin Wang, Yu Yang, Yu-Pei Zhao, Tai-Ping Zhang, Quan Liao and Hong Shu
Funding Agency and Grant Number
Funding Agency Grant Number
Translational Research of Early Diagnosis and Comprehensive Treatment in Pancreatic Cancer 201202007
Corresponding Author Yu-Pei Zhao, MD, Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, No. 1 Shuai Fu Yuan, Dongcheng District, Beijing 100005, China. zhao8028@263.net
Key Words 5-fluorouracil; Resistance; Transporters; Metabolic enzyme; Signaling pathway; Stromal factors; MicroRNA; Proteomic investigation
Core Tip 5-fluorouracil (5-FU) is one of the most important drugs for human pancreatic cancer. Although recent studies have questioned the effectiveness of 5-FU against pancreatic cancer, it remains a good choice for pancreatic cancer. Our paper discusses recent studies that provide novel insights into 5-FU chemotherapy in pancreatic cancer.
Publish Date 2014-11-17 15:12
Citation Wang WB, Yang Y, Zhao YP, Zhang TP, Liao Q, Shu H. Recent studies of 5-fluorouracil resistance in pancreatic cancer. World J Gastroenterol 2014; 20(42): 15682-15690
URL http://www.wjgnet.com/1007-9327/full/v20/i42/15682.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i42.15682
Full Article (PDF) WJG-20-15682.pdf
Full Article (Word) WJG-20-15682.doc
Manuscript File 9595-Review.doc
Answering Reviewers 9595-Answering reviewers.pdf
Copyright License Agreement 9595-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 9595-Language certificate.pdf
Peer-review Report 9595-Peer reviews.pdf
Scientific Misconduct Check 9595-CrossCheck.jpg
Scientific Editor Work List 9595-Scientific editor work list.pdf